Oncology Meeting Resources
- 17 Feb 2016,
The 2016 programme looked at the different “models” which mark the today’s diversified world of sarcomas. While in the last 15 years GIST have been shaping the model of targeted therapies in solid cancers, STS have always provided a model for local surgical control in challenging anatomical sites. Some models somehow replicate the GIST model and others deeply deviate in regard to the use of molecularly targeted therapies, and a STS immune therapy model is awaited. These many models attracted an audience of experts in sarcomas and were discussed by a world-renowned faculty highlighting each of the diverse models in a multidisciplinary fashion, always merging translational science and pathology with clinical treatment aspects.
Presentations and webcasts from the ESMO Sarcoma & GIST Conference 2016 are now available here to ESMO members. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.